Skip to content
★ Sign in to follow
DH

Dexxon Holdings Ltd.

Related company / holding
Urovant Sciences Ltd.Myovant Sciences Ltd.Sio Gene Therapies Inc.
Total declarations
32
Companies
3
▲ Purchases (32 ops.)
€108.5M
▼ Sales (0 ops.)
—

Latest filing published 19 Jun 2019 for Urovant Sciences Ltd., €50k.

Filing timeline

BuySale
Dexxon Holdings Ltd.

Insider track record

Disclosed buys
32
Disclosed sells
0
Signal history

Closed purchases

Market purchases
32

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Dexxon Holdings Ltd.: trading record in brief

Filings by Dexxon Holdings Ltd. span 3 companies, the busiest being Urovant Sciences Ltd., Sio Gene Therapies Inc. and Myovant Sciences Ltd. The record holds 32 filings, for trades running from 2 April 2018 to 19 June 2019.

Every open-market trade on record is a purchase: 32 purchases worth €108.5M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2019, the count stands at 28 purchases and no sales.

Half of the purchases are above €50k and half below. 32 out of 32 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 19 June 2019 with an open-market purchase (€50k) in Urovant Sciences Ltd. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Dexxon Holdings Ltd.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.

    Same trade as the filing by QVT Associates GP LLC, counted once

    55,825 USD29SEC
    6,541 shares@ US$8.53460.1% of flowCommon Shares, $0.000037453 par value per shareSEC:0001144204-19-031542:0
    Canonical exit: 15 Sept 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.

    Same trade as the filing by QVT Associates GP LLC, counted once

    55,061 USD29SEC
    6,706 shares@ US$8.21070.1% of flowCommon SharesSEC:0001144204-19-031542:1
    Canonical exit: 16 Sept 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.

    Same trade as the filing by QVT Associates GP LLC, counted once

    40,495 USD29SEC
    4,957 shares@ US$8.16930.1% of flowCommon SharesSEC:0001144204-19-031542:2
    Canonical exit: 17 Sept 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.

    Same trade as the filing by Viking Global Performance LLC, counted once

    62,244 USD29SEC
    7,500 shares@ US$8.29920.2% of flowCommon Shares, $0.000037453 par value per shareSEC:0001144204-19-031054:0
    Canonical exit: 10 Sept 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.

    Same trade as the filing by Viking Global Performance LLC, counted once

    58,543 USD29SEC
    7,367 shares@ US$7.94660.2% of flowCommon SharesSEC:0001144204-19-031054:1
    Canonical exit: 11 Sept 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.

    Same trade as the filing by Viking Global Performance LLC, counted once

    56,514 USD29SEC
    7,144 shares@ US$7.91070.1% of flowCommon SharesSEC:0001144204-19-031054:2
    Canonical exit: 12 Sept 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.

    Same trade as the filing by Viking Global Performance LLC, counted once

    61,694 USD29SEC
    7,189 shares@ US$8.58170.2% of flowCommon SharesSEC:0001144204-19-030612:2
    Canonical exit: 9 Sept 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.

    Same trade as the filing by Viking Global Performance LLC, counted once

    52,959 USD29SEC
    6,649 shares@ US$7.9650.1% of flowCommon Shares, $0.000037453 par value per shareSEC:0001144204-19-030612:0
    Canonical exit: 5 Sept 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.

    Same trade as the filing by Viking Global Performance LLC, counted once

    62,594 USD29SEC
    7,500 shares@ US$8.34590.2% of flowCommon SharesSEC:0001144204-19-030612:1
    Canonical exit: 8 Sept 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.

    Same trade as the filing by SVF Investments (UK) Ltd, counted once

    56,911 USD29SEC
    7,500 shares@ US$7.58810.2% of flowCommon Shares, $0.000037453 par value per shareSEC:0001144204-19-030138:0
    Canonical exit: 2 Sept 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.

    Same trade as the filing by SVF Investments (UK) Ltd, counted once

    52,418 USD29SEC
    6,540 shares@ US$8.0150.1% of flowCommon SharesSEC:0001144204-19-030138:1
    Canonical exit: 3 Sept 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.

    Same trade as the filing by SVF Investments (UK) Ltd, counted once

    56,621 USD29SEC
    7,082 shares@ US$7.99510.1% of flowCommon SharesSEC:0001144204-19-030138:2
    Canonical exit: 4 Sept 2019 (T+90)
  • ▲
    Related company / holdingExecutivesMyovant Sciences Ltd.

    Same trade as the filing by QVT Associates GP LLC, counted once

    20M USD28SEC
    2,424,242 shares@ US$8.2549.3% of flowCommon Shares, $0.000017727 par value per shareSEC:0001144204-19-030140:0
    Canonical exit: 2 Sept 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.
    55,418 USD29SEC
    6,951 shares@ US$7.97260.1% of flowCommon Shares, $0.000037453 par value per shareSEC:0001144204-19-029540:0
    Canonical exit: 28 Aug 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.
    2,672 USD29SEC
    300 shares@ US$8.90660.0% of flowCommon SharesSEC:0001144204-19-029540:1
    Canonical exit: 28 Aug 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.
    39,042 USD29SEC
    5,071 shares@ US$7.69910.1% of flowCommon SharesSEC:0001144204-19-029540:2
    Canonical exit: 29 Aug 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.
    41,815 USD29SEC
    5,424 shares@ US$7.70920.1% of flowCommon SharesSEC:0001144204-19-029540:3
    Canonical exit: 1 Sept 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.
    29,233 USD29SEC
    3,796 shares@ US$7.70110.1% of flowCommon Shares, $0.000037453 par value per shareSEC:0001144204-19-028688:0
    Canonical exit: 22 Aug 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.
    29,245 USD29SEC
    3,807 shares@ US$7.68180.1% of flowCommon SharesSEC:0001144204-19-028688:1
    Canonical exit: 26 Aug 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.
    51,983 USD29SEC
    6,882 shares@ US$7.55350.1% of flowCommon SharesSEC:0001144204-19-028688:2
    Canonical exit: 27 Aug 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.

    Same trade as the filing by SVF Investments (UK) Ltd, counted once

    40,558 USD29SEC
    5,033 shares@ US$8.05840.1% of flowCommon Shares, $0.000037453 par value per shareSEC:0001144204-19-028456:0
    Canonical exit: 20 Aug 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.

    Same trade as the filing by SVF Investments (UK) Ltd, counted once

    37,252 USD29SEC
    4,802 shares@ US$7.75760.1% of flowCommon SharesSEC:0001144204-19-028456:1
    Canonical exit: 21 Aug 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.
    85,108 USD29SEC
    9,995 shares@ US$8.51510.2% of flowCommon Shares, $0.000037453 par value per shareSEC:0001144204-19-027995:0
    Canonical exit: 19 Aug 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.

    Same trade as the filing by QVT Associates GP LLC, counted once

    66,142 USD29SEC
    8,285 shares@ US$7.98330.2% of flowCommon Shares, $0.000037453 par value per shareSEC:0001144204-19-027731:0
    Canonical exit: 18 Aug 2019 (T+90)
  • ▲
    Related company / holdingExecutivesUrovant Sciences Ltd.

    Same trade as the filing by QVT Associates GP LLC, counted once

    14,383 USD29SEC
    1,715 shares@ US$8.38670.0% of flowCommon SharesSEC:0001144204-19-027731:1
    Canonical exit: 18 Aug 2019 (T+90)

25 of 10 declarations